CGM maker Dexcom (Nasdaq: DXCM) is adding the former CFO of orthopedic and surgical device giant Stryker to its board of directors. Glenn Boehnlein’s appointment was in effect yesterday — the day of the announcement. Boehnlein’s addition expands the size of Dexcom’s board to 13. Boehnlein retired from Stryker last year after 22 years with […]
Personnel Moves
ViCentra names new CFO, adds board member
ViCentra announced today that it appointed Ian Wells as its new CFO and added Thomas A. West to its board of directors. Wells’ appointment went into effect on June 19, 2026, while West became an independent director on July 1, 2026. The Utrecht, the Netherlands-based automated insulin delivery system developer said the appointments lay the […]
BD names new president of Pharmacy Automation biz
BD (NYSE:BDX) announced today that it appointed Matthew Sassone as worldwide president of its Pharmacy Automation business. Sassone now leads the global business within the BD Medication Management Solutions business unit. His appointment goes into effect immediately. In the role, Sassone’s responsibilities include driving global strategy, performance and growth for Pharmacy Automation as part of […]
MiniMed adds Alcon CEO, Medtronic exec to board of directors
MiniMed (Nasdaq:MMED) announced today that it appointed David Endicott and Linnea Burman to its board of directors, effective today. The appointments of Endicott and Burman expand MiniMed’s board from nine members to 11 members. Endicott, currently the CEO of Alcon, also joins the board’s Compensation and Talent Committee with the appointment. Northridge, California-based MiniMed’s latest […]
Insulet adds new board director
Insulet (Nasdaq:PODD) announced today that it appointed Jonathan (“Jay”) Mazelsky to its board of directors, effective July 1. Mazelsky joins the Acton, Massachusetts-based automated insulin delivery technology developer‘s board as an independent director. “We are pleased to welcome Jay to Insulet’s board of directors,” said Insulet President and CEO Ashley McEvoy. “Jay has a strong […]
Insulet has a new chief R&D officer
Insulet (Nasdaq:PODD) announced today on social media that it appointed Dr. Divakar Ramakrishnan as its new chief R&D officer. In a LinkedIn post, the company said Ramakrishnan will lead its R&D organization. His focus centers around strengthening Insulet’s capabilities in delivering innovation around the world. Ramakrishnan joins as the company continues to advance its automated […]
Embecta names new SVP and president, North America
Embecta (Nasdaq:EMBC) announced that it appointed Nimish Muzumdar as its new SVP and president, North America. Muzumdar holds responsibility for leading the company’s U.S. and Canada commercial teams, executing the region’s long-term growth strategy. He reports to Chair, President and CEO, Dev Kurdikar, and serves on the Embecta operating team. His appointment went into effect […]
MiniMed has a new board member following Brett Wall’s Medtronic departure
MiniMed (Nasdaq:MMED) announced the appointment of Scott Cundy to its board of directors, effective July 3, 2026. Cundy’s appointment comes in the wake of Brett Wall’s departure from MiniMed parent company, Medtronic, announced this week. Wall, the EVP and president of the Medtronic Neuroscience portfolio, served as a class II director for MiniMed and as […]
Tandem Diabetes Care terminates chief commercial officer
Tandem Diabetes Care (Nasdaq:TNDM) recently said in an SEC filing that it terminated the employment of chief commercial officer Mark Novara. The SEC Form 8-K, filed on May 15, says that the company notified Novara, an EVP in addition to serving as CCO, on May 11 that his employment was being terminated without cause. The […]
CGM maker Sava names new chief commercial officer
Sava Technologies today announced the appointment of John Bernard as its new chief commercial officer (CCO). London-based Sava, which develops a minimally invasive molecular sensing platform for continuous glucose monitoring (CGM), says the appointment marks a “decisive step” in its transition from clinical and technical progress to commercial execution. The company designed its multi-molecule biosensor […]
